Recro Pharma Inc (REPH) - Financial and Strategic SWOT Analysis Review

  • ID: 4278716
  • SWOT Analysis
  • 50 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Adare Pharmaceuticals Inc
  • Adynxx Inc
  • Avenue Therapeutics Inc
  • Cara Therapeutics Inc
  • Catalent Inc
  • Depomed Inc
  • MORE
Recro Pharma Inc (REPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Recro Pharma Inc (Recro Pharma) is a specialty pharmaceutical company that focuses on developing novel products for commercialization in hospital and other acute care settings and provides contract development and manufacturing (CDMO) services. The company is developing IV/IM Meloxicam, a proprietary, rapid-onset, long-acting preferential COX-2 inhibitor for the treatment of acute post-operative pain and acute pain; and Dex-IN, a proprietary intranasal formulation of dexmedetomidine for the treatment of peri-procedural pain and cancer breakthrough pain. It also develops and manufactures pharmaceutical products based on its proprietary delivery technologies for commercial partners. Recro Pharma is headquartered in Malvern, Pennsylvania, the US.

Recro Pharma Inc Key Recent Developments

May 09, 2018: Recro Pharma Reports First Quarter 2018 Financial Results
May 02, 2018: Recro Pharma Announces Commercial Team Additions
Mar 29, 2018: Recro Pharma Announces Commercial Team Additions
Mar 02, 2018: Recro Pharma Announces Commercial Team Additions
Feb 27, 2018: Recro Pharma Announces Year End 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Adare Pharmaceuticals Inc
  • Adynxx Inc
  • Avenue Therapeutics Inc
  • Cara Therapeutics Inc
  • Catalent Inc
  • Depomed Inc
  • MORE
Section 1 - About the Company
  • Recro Pharma Inc - Key Facts
  • Recro Pharma Inc - Key Employees
  • Recro Pharma Inc - Key Employee Biographies
  • Recro Pharma Inc - Major Products and Services
  • Recro Pharma Inc - History
  • Recro Pharma Inc - Company Statement
  • Recro Pharma Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Recro Pharma Inc - Business Description
  • Business Segment: Acute Care
  • Overview
  • Business Segment: Contract Development and Manufacturing
  • Overview
  • Performance
  • R&D Overview
  • Recro Pharma Inc - Corporate Strategy
  • Recro Pharma Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Recro Pharma Inc - Strengths
  • Recro Pharma Inc - Weaknesses
  • Recro Pharma Inc - Opportunities
  • Recro Pharma Inc - Threats
  • Recro Pharma Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Recro Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Recro Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Recro Pharma Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 09, 2018: Recro Pharma Reports First Quarter 2018 Financial Results
  • May 02, 2018: Recro Pharma Announces Commercial Team Additions
  • Mar 29, 2018: Recro Pharma Announces Commercial Team Additions
  • Mar 02, 2018: Recro Pharma Announces Commercial Team Additions
  • Feb 02, 2018: Recro Pharma Announces Key Sales Team Additions
  • Nov 20, 2017: Recro Pharma Secures $100M Credit Facility
  • Nov 09, 2017: Recro Pharma Reports Third Quarter 2017 Financial Results
  • Aug 21, 2017: Recro Pharma Appoints Jyrki Mattila as Executive Vice President of Business Development
  • Aug 10, 2017: Recro Pharma Reports Second Quarter 2017 Financial Results
  • Jun 16, 2017: Recro Pharma to Participate in Hospital Drug Launch Panel at the JMP Life Sciences Conference
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Recro Pharma Inc, Key Facts
  • Recro Pharma Inc, Key Employees
  • Recro Pharma Inc, Key Employee Biographies
  • Recro Pharma Inc, Major Products and Services
  • Recro Pharma Inc, History
  • Recro Pharma Inc, Subsidiaries
  • Recro Pharma Inc, Key Competitors
  • Recro Pharma Inc, Ratios based on current share price
  • Recro Pharma Inc, Annual Ratios
  • Recro Pharma Inc, Annual Ratios
  • Recro Pharma Inc, Annual Ratios
  • Recro Pharma Inc, Interim Ratios
  • Recro Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Recro Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Recro Pharma Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Recro Pharma Inc, Performance Chart (2013 - 2017)
  • Recro Pharma Inc, Ratio Charts
  • Recro Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Recro Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Trevena Inc
  • Sandoz AG
  • PATHEON HOLDINGS COOPERATIEF U.A.
  • Pacira Pharmaceuticals Inc
  • Metrics Inc
  • MallInckrodt Plc
  • Depomed Inc
  • Catalent Inc
  • Cara Therapeutics Inc
  • Avenue Therapeutics Inc
  • Adynxx Inc
  • Adare Pharmaceuticals Inc
  • AcelRx Pharmaceuticals Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll